Export 258 results:
[ Author(Asc)] Title Type Year
Filters: First Letter Of Last Name is C  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
C
J. B. Copley, Staffeld, C., Lindberg, J., Hansen, A., Bailey, C., Anand, R., and Van Veldhuisen, P., “Cyclosporine to tacrolimus: effect on hypertension and lipid profiles in renal allografts.”, Transplant Proc, vol. 30, no. 4, pp. 1254-6, 1998.
M. - A. Conteh, Goldstein, S. T., Wurie, H. R., Gidudu, J., Lisk, D. Radcliffe, Carter, R. J., Seward, J. F., Hampton, L. M., Wang, D., Andersen, L. E., Arvay, M., Schrag, S. J., Dawson, P., Fombah, A. E., Petrie, C. R., Feikin, D. R., Russell, J. B. W., Lindblad, R., Kargbo, S. A. S., Samai, M., and Mahon, B. E., “Clinical Surveillance and Evaluation of Suspected Ebola Cases in a Vaccine Trial During an Ebola Epidemic: The Sierra Leone Trial to Introduce a Vaccine Against Ebola.”, J Infect Dis, vol. 217, no. suppl_1, pp. S33-S39, 2018.
H. Microbiome Consortium and Simone, G., “A Framework for Human Microbiome Research”, Nature, vol. 486, pp. 215-221, 2012.
“Structure, Function and Diversity of the Healthy Human Microbiome”, Nature, vol. 486, no. 7402, pp. 207-14, 2012.
H. Microbiome Consortium and Simone, G., “Structure, Function and Diversity of the Healthy Human Microbiome”, Nature, vol. 486, pp. 207-214, 2012.
“A Framework for Human Microbiome Research”, Nature, vol. 486, no. 7402, pp. 215-21, 2012.
B. A. Conley, Gore-Langton, R. E., and Cheson, B. D., “Clinical trials, referral resource. Treatment of advanced or recurrent squamous cell carcinoma of the head and neck.”, Oncology (Williston Park), vol. 14, no. 4, pp. 553-4, 559, 561, 2000.
B. A. Conley, Gore-Langton, R. E., and Cheson, B. D., “Clinical trials resource. Treatment of advanced or recurrent squamous cell carcinoma of the head and neck”, Oncology, vol. 14, pp. 553-554559 561, 2000.
B. A. Conley, Enos, R. A., and Cheson, B. D., “Clinical trials referral resource. Targeted therapy in squamous cell cancers of the head and neck.”, Oncology (Williston Park), vol. 16, no. 5, pp. 621-2, 625-6, 2002.
R. B. Colvin, Cohen, A. H., Saiontz, C., Bonsib, S., Buick, M., Burke, B., Carter, S., Cavallo, T., Haas, M., Lindblad, A., Manivel, J. C., Nast, C. C., Salomon, D., Weaver, C., and Weiss, M., “Evaluation of pathologic criteria for acute renal allograft rejection: reproducibility, sensitivity, and clinical correlation.”, J Am Soc Nephrol, vol. 8, no. 12, pp. 1930-41, 1997.
M. H. Collins, Potter, G. E., Hitchings, M. D. T., Butler, E., Wiles, M., Kennedy, J. K., Pinto, S. B., Teixeira, A. B. M., Casanovas-Massana, A., Rouphael, N. G., Deye, G. A., Simmons, C. P., Moreira, L. A., Nogueira, M. L., Cummings, D., Ko, A., Teixeira, M. M., and Edupuganti, S., “EVITA Dengue: a Cluster-Randomized Controlled Trial to EValuate the Efficacy of Wolbachia-InfecTed Aedes aegypti mosquitoes in reducing the incidence of Arboviral Infection in Brazil”, Trials, vol. 23, no. 1, p. 185, 2022.
D. Collie, Gay, K., Sheikh, M., Esterlitz, J., Saver, J., Warach, S., and Janis, Son behalf, “Stroke Version 2.0 Common Data Element (CDE) Review: Updates to the National Institute of Neurological Disorders and Stroke (NINDS) CDEs for Stroke”, in American Academy of Neurology 71st Annual Meeting, Philadelphia, PA, 2019.
D. Collie, Gay, K., Sheikh, M., Esterlitz, J., Saver, J., Warach, S., M. Mendoza-Puccini, C., Janis, S., and Group, S. V. 2.0 C. D. E. W., “The National Institute of Neurological Disorders and Stroke (NINDS) Updates to the Spinal Cord Injury (SCI) Common Data Element Recommendations”. 2019.
A. D. Colevas, West, P. J., and Cheson, B. D., “Clinical trials referral resource. Current clinical trials of epothilone B analog (BMS-247550).”, Oncology (Williston Park), vol. 15, no. 9, pp. 1168-9, 1172-5, 2001.
D. A Colevas, Scharf, O., and Schoenfeldt, M., “Clinical trials referral resource. Current clinical trials of cilengitide, an alpha(v) antagonist in clinical development as an anticancer agent.”, Oncology (Williston Park), vol. 18, no. 14, pp. 1778, 1781-2, 1784, 2004.
V. H. Coleman-Cowger, Oga, E. A., Peters, E. N., Trocin, K. E., Koszowski, B., and Mark, K., “Accuracy of Three Screening Tools for Prenatal Substance Use.”, Obstet Gynecol, vol. 133, no. 5, pp. 952-961, 2019.
C. H. Cole, Oden, N. L., Lindblad, A. S., Phelps, D. L., and Palmer, E. A., “Abstract CRYO-ROP risk model prediction of retinopathy (RM-ROP) progression from prethreshold (Th) ROP”, 2000.
M. Cohen-Wolkowiez, Sampson, M., Bloom, B. T., Arrieta, A., Wynn, J. L., Martz, K., Harper, B., Kearns, G. L., Capparelli, E. V., Siegel, D., Benjamin, D. K., and P Smith, B., “Determining Population and Developmental Pharmacokinetics of Metronidazole using Plasma and Dried Blood Spot Samples from Premature Infants”, Pediatr Infect Dis J, vol. 32, no. 9, pp. 956-61, 2013.
M. Cohen-Wolkowiez, Sampson, M., Bloom, B. T., Arrieta, A., Wynn, J. L., Martz, K., Harper, B., Kearns, G. L., Capparelli, E. V., Siegel, D., Benjamin, Jr, D. K., Smith, P. B., and BCPA), T. Best Pharm, “Determining Population and Developmental Pharmacokinetics of Metronidazole Using Plasma and Dried Blood Spot Samples from Premature Infants”, Pediatr Infect Dis J, vol. 32, pp. 956-961, 2013.
M. Cohen-Wolkowiez, Poindexter, B., Bidegain, M., Weitkamp, J. - H., Schelonka, R. L., Randolph, D. A., Ward, R. M., Wade, K., Valencia, G., Burchfield, D., Arrieta, A., Mehta, V., Walsh, M., Kantak, A., Rasmussen, M., Sullivan, J. E., Finer, N., Rich, W., Brozanski, B. S., van den Anker, J., Blumer, J., Laughon, M., Watt, K. M., Kearns, G. L., Capparelli, E. V., Martz, K., Berezny, K., Benjamin, D. K., and P Smith, B., “Safety and effectiveness of meropenem in infants with suspected or complicated intra-abdominal infections.”, Clin Infect Dis, vol. 55, no. 11, pp. 1495-502, 2012.
M. J. Cohen, Meador, K., Browning, N., Baker, G. A., Clayton-Smith, J., Kalayjian, L. A., Kanner, A., Liporace, J., Pennell, P., Privitera, M., and Loring, D., “Fetal Antiepileptic Drug Exposure: Motor, Adaptive and Emotional/Behavioral Functioning at Age 3”, Epilepsy Behav, vol. 22, pp. 240-246, 2011.
G. R. Cohen, Curet, L. B., Levine, R. J., Ewell, M. G., Morris, C. D., Catalano, P. M., Clokey, D., and Klebanoff, M. A., “Ethnicity, nutrition, and birth outcomes in nulliparous women.”, Am J Obstet Gynecol, vol. 185, no. 3, pp. 660-7, 2001.
C. R. Cohen, Wierzbicki, M. R., French, A. L., Morris, S., Newmann, S., Reno, H., Green, L., Miller, S., Powell, J., Parks, T., and Hemmerling, A., “Randomized Trial of Lactin-V to Prevent Recurrence of Bacterial Vaginosis.”, N Engl J Med, vol. 382, no. 20, pp. 1906-1915, 2020.
S. Cohen, Boron, M., Cohen, A., Van Veldhuisen, P., and Registry, T. Palivizuma, “Group patterns of RSV disease prophylaxis in infants with congenital heart disease (CHD): preliminary results from the 2002-2003 Palivizumab Outcomes Registry”, 2003.
M. J. Cohen, Meador, K. J., Browning, N., May, R., Baker, G. A., Clayton-Smith, J., Kalayjian, L. A., Kanner, A., Liporace, J. D., Pennell, P. B., Privitera, M., and Loring, D. W., “Fetal antiepileptic drug exposure: Adaptive and emotional/behavioral functioning at age 6years.”, Epilepsy Behav, vol. 29, no. 2, pp. 308-15, 2013.